Updated:
Symeres
Symeres is a Contract Research Organization founded in 1987 in Nijmegen, Netherlands. The company provides services including medicinal chemistry, in vitro...
Symeres
Symeres is a Contract Research Organization founded in 1987 in Nijmegen, Netherlands. The company provides services including medicinal chemistry, in vitro pharmacology, ADME-Tox analysis, process research, development, and GMP manufacturing. Symeres supports the pharmaceutical and biotech industries with services from hit finding to early clinical drug substance APIs.
General information
Firm type
Asset Manager
Location
Region
Europe
Country
Netherlands
City
Nijmegen
Corporate office
Groningen, Netherlands
Frequently asked questions
What is Symeres?
Public information about Symeres is scarce. The firm is registered in Groningen, Netherlands, but its business activities — whether asset management, advisory, or operating company — are not disclosed in available public records. No website, LinkedIn page, or media coverage has been identified.
Who runs Symeres?
No named principals, executives, or investment professionals at Symeres appear in the public domain. The firm's leadership structure is unknown.
Does Symeres manage capital for external investors?
There is no public evidence that Symeres manages third-party capital, operates an investment fund, or has a registered AUM. The firm's client base and investment vehicle structure are not disclosed.
Which sectors does Symeres focus on?
Given its base in Groningen — a hub for life sciences and chemistry — Symeres may target those sectors, but no sector focus has been confirmed in public sources. The firm's sector tags are unverified.
Has Symeres been involved in any recent deals or partnerships?
No recent deals, investments, or operational events involving Symeres have been reported in credible business media or public filings. Recent activity is unverifiable.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: